<DOC>
	<DOCNO>NCT00520598</DOCNO>
	<brief_summary>The purpose study evaluate safety immunogenicity V505 comparison GARDASIL ( TM )</brief_summary>
	<brief_title>Broad Spectrum HPV ( Human Papillomavirus ) Vaccine 16 26 Year Old Women ( V505-001 )</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Vulvar Neoplasms</mesh_term>
	<mesh_term>Papillomavirus Infections</mesh_term>
	<mesh_term>Condylomata Acuminata</mesh_term>
	<mesh_term>Vaginal Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Female 16 26 year old Has never Pap test normal Pap test result Lifetime history 0 4 sexual partner History abnormal cervical biopsy result ; History positive test HPV ; History external genital/vaginal wart ; Currently user illegal drug alcohol abuser History severe allergic reaction require medical attention Are pregnant Received market HPV vaccine Currently enrol clinical trial Currently ( history ) certain medical condition currently take take certain medication ( detail discuss time consent )</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>26 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>